View Future GrowthSamyoungLtd 과거 순이익 실적과거 기준 점검 5/6SamyoungLtd은 연평균 35.8%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 1.1% 증가했습니다. 매출은 연평균 1.1%의 비율로 증가했습니다. SamyoungLtd의 자기자본이익률은 17%이고 순이익률은 8.6%입니다.핵심 정보35.75%순이익 성장률36.73%주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률1.12%자기자본이익률17.04%순이익률8.60%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 21Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₩400 (up from ₩243 in FY 2024). Revenue: ₩153.2b (up 22% from FY 2024). Net income: ₩13.2b (up 63% from FY 2024). Profit margin: 8.6% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 19Second quarter 2025 earnings released: EPS: ₩43.00 (vs ₩101 in 2Q 2024)Second quarter 2025 results: EPS: ₩43.00 (down from ₩101 in 2Q 2024). Revenue: ₩33.4b (flat on 2Q 2024). Net income: ₩1.42b (down 58% from 2Q 2024). Profit margin: 4.3% (down from 10% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.분석 기사 • May 24Some Investors May Be Willing To Look Past SamyoungLtd's (KRX:003720) Soft EarningsThe most recent earnings report from Samyoung Co.,Ltd. ( KRX:003720 ) was disappointing for shareholders. However, our...분석 기사 • Nov 22SamyoungLtd's (KRX:003720) Earnings Are Weaker Than They SeemDespite posting some strong earnings, the market for Samyoung Co.,Ltd.'s ( KRX:003720 ) stock hasn't moved much. We did...Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩51.00 (vs ₩52.65 in 3Q 2023)Third quarter 2024 results: EPS: ₩51.00 (down from ₩52.65 in 3Q 2023). Revenue: ₩31.2b (up 5.4% from 3Q 2023). Net income: ₩1.69b (down 4.2% from 3Q 2023). Profit margin: 5.4% (down from 6.0% in 3Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.분석 기사 • Mar 31Why SamyoungLtd's (KRX:003720) Healthy Earnings Aren’t As Good As They SeemSolid profit numbers didn't seem to be enough to please Samyoung Co.,Ltd.'s ( KRX:003720 ) shareholders. Our analysis...모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩13,180, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 201% over the past three years.Buy Or Sell Opportunity • Apr 24Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 99% to ₩11,060. The fair value is estimated to be ₩9,119, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.New Risk • Apr 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (74% net debt to equity). Share price has been volatile over the past 3 months (13% average weekly change).Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩8,130, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 124% over the past three years.분석 기사 • Apr 13What Is Samyoung Co.,Ltd.'s (KRX:003720) Share Price Doing?While Samyoung Co.,Ltd. ( KRX:003720 ) might not have the largest market cap around , it received a lot of attention...Buy Or Sell Opportunity • Apr 07Now 22% undervaluedOver the last 90 days, the stock has risen 16% to ₩6,800. The fair value is estimated to be ₩8,747, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.Buy Or Sell Opportunity • Mar 23Now 21% undervaluedOver the last 90 days, the stock has risen 6.4% to ₩6,800. The fair value is estimated to be ₩8,605, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.Reported Earnings • Mar 21Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₩400 (up from ₩243 in FY 2024). Revenue: ₩153.2b (up 22% from FY 2024). Net income: ₩13.2b (up 63% from FY 2024). Profit margin: 8.6% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.공시 • Mar 04Samyoung Co.,Ltd., Annual General Meeting, Mar 31, 2026Samyoung Co.,Ltd., Annual General Meeting, Mar 31, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 565, gyeongin-ro, guro-gu, seoul South KoreaValuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩9,170, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 207% over the past three years.분석 기사 • Feb 11Samyoung Co.,Ltd. (KRX:003720) Looks Just Right With A 46% Price JumpSamyoung Co.,Ltd. ( KRX:003720 ) shareholders have had their patience rewarded with a 46% share price jump in the last...Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,530, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 133% over the past three years.분석 기사 • Jan 12At ₩5,640, Is It Time To Put Samyoung Co.,Ltd. (KRX:003720) On Your Watch List?While Samyoung Co.,Ltd. ( KRX:003720 ) might not have the largest market cap around , it received a lot of attention...Upcoming Dividend • Dec 22Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩7,460, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 186% over the past three years.분석 기사 • Nov 27Subdued Growth No Barrier To Samyoung Co.,Ltd. (KRX:003720) With Shares Advancing 32%Samyoung Co.,Ltd. ( KRX:003720 ) shareholders have had their patience rewarded with a 32% share price jump in the last...Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 30%After last week's 30% share price gain to ₩6,000, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 125% over the past three years.New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Profit margins are more than 30% lower than last year (5.5% net profit margin).Declared Dividend • Nov 08Dividend of ₩20.00 announcedDividend of ₩20.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.공시 • Nov 07Samyoung Co.,Ltd. announces Annual dividend, payable on April 28, 2026Samyoung Co.,Ltd. announced Annual dividend of KRW 20.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩5,310, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 117% over the past three years.New Risk • Aug 19New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Profit margins are more than 30% lower than last year (5.5% net profit margin).Reported Earnings • Aug 19Second quarter 2025 earnings released: EPS: ₩43.00 (vs ₩101 in 2Q 2024)Second quarter 2025 results: EPS: ₩43.00 (down from ₩101 in 2Q 2024). Revenue: ₩33.4b (flat on 2Q 2024). Net income: ₩1.42b (down 58% from 2Q 2024). Profit margin: 4.3% (down from 10% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.분석 기사 • Aug 14Samyoung Co.,Ltd. (KRX:003720) Stocks Shoot Up 25% But Its P/E Still Looks ReasonableKOSE:A003720 1 Year Share Price vs Fair Value Explore SamyoungLtd's Fair Values from the Community and select yours...공시 • Jun 19Samyoung Co.,Ltd. (KOSE:A003720) agreed to acquire 99.63% stake in CASCO Co., Ltd. from PTclover Co., Ltd. for KRW 35.5 billion.Samyoung Co.,Ltd. (KOSE:A003720) agreed to acquire 99.63% stake in CASCO Co., Ltd. from PTclover Co., Ltd. for KRW 35.5 billion on June 18, 2025. A cash consideration of KRW 35.5 billion will be paid by Samyoung Co.,Ltd. As part of consideration, KRW 35.5 billion is paid towards common equity of CASCO Co., Ltd. The expected completion of the transaction is July 1, 2025.분석 기사 • May 24Some Investors May Be Willing To Look Past SamyoungLtd's (KRX:003720) Soft EarningsThe most recent earnings report from Samyoung Co.,Ltd. ( KRX:003720 ) was disappointing for shareholders. However, our...분석 기사 • Apr 16Market Participants Recognise Samyoung Co.,Ltd.'s (KRX:003720) EarningsSamyoung Co.,Ltd.'s ( KRX:003720 ) price-to-earnings (or "P/E") ratio of 16.3x might make it look like a sell right now...New Risk • Mar 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.4% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.4% net profit margin). Market cap is less than US$100m (₩131.9b market cap, or US$89.8m).공시 • Mar 07Samyoung Co.,Ltd., Annual General Meeting, Mar 28, 2025Samyoung Co.,Ltd., Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 565, gyeongin-ro, guro-gu, seoul South Korea분석 기사 • Feb 19Is SamyoungLtd (KRX:003720) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩4,835, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years.분석 기사 • Jan 20We Ran A Stock Scan For Earnings Growth And SamyoungLtd (KRX:003720) Passed With EaseThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩4,325, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 33% over the past three years.Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. Payout ratio is a comfortable 4.6% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩3,750, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 31% over the past three years.분석 기사 • Dec 09The Market Doesn't Like What It Sees From Samyoung Co.,Ltd.'s (KRX:003720) Earnings Yet As Shares Tumble 26%To the annoyance of some shareholders, Samyoung Co.,Ltd. ( KRX:003720 ) shares are down a considerable 26% in the last...분석 기사 • Nov 22SamyoungLtd's (KRX:003720) Earnings Are Weaker Than They SeemDespite posting some strong earnings, the market for Samyoung Co.,Ltd.'s ( KRX:003720 ) stock hasn't moved much. We did...Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩51.00 (vs ₩52.65 in 3Q 2023)Third quarter 2024 results: EPS: ₩51.00 (down from ₩52.65 in 3Q 2023). Revenue: ₩31.2b (up 5.4% from 3Q 2023). Net income: ₩1.69b (down 4.2% from 3Q 2023). Profit margin: 5.4% (down from 6.0% in 3Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.New Risk • Nov 05New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩137.8b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩137.8b market cap, or US$99.9m).분석 기사 • Sep 26There's Been No Shortage Of Growth Recently For SamyoungLtd's (KRX:003720) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...분석 기사 • Sep 04Samyoung Co.,Ltd. (KRX:003720) Held Back By Insufficient Growth Even After Shares Climb 36%Samyoung Co.,Ltd. ( KRX:003720 ) shares have had a really impressive month, gaining 36% after a shaky period...분석 기사 • Sep 03Do SamyoungLtd's (KRX:003720) Earnings Warrant Your Attention?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩3,080, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 8.6% over the past three years.분석 기사 • Jun 18SamyoungLtd (KRX:003720) Is Looking To Continue Growing Its Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Mar 31Why SamyoungLtd's (KRX:003720) Healthy Earnings Aren’t As Good As They SeemSolid profit numbers didn't seem to be enough to please Samyoung Co.,Ltd.'s ( KRX:003720 ) shareholders. Our analysis...New Risk • Mar 19New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.8b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₩132.8b market cap, or US$99.2m).New Risk • Jan 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.7b (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₩132.7b market cap, or US$99.4m).New Risk • Nov 25New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 3.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin).Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩4,930, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 172% over the past three years.Reported Earnings • Aug 20Second quarter 2023 earnings released: EPS: ₩37.00 (vs ₩6.00 in 2Q 2022)Second quarter 2023 results: EPS: ₩37.00 (up from ₩6.00 in 2Q 2022). Revenue: ₩33.6b (down 6.4% from 2Q 2022). Net income: ₩1.25b (up ₩1.05b from 2Q 2022). Profit margin: 3.7% (up from 0.6% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.New Risk • Aug 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.2b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (86% net debt to equity). Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (₩130.2b market cap, or US$99.5m).Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩4,840, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 240% over the past three years.Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩44.00 (vs ₩40.00 in 1Q 2022)First quarter 2023 results: EPS: ₩44.00 (up from ₩40.00 in 1Q 2022). Revenue: ₩34.4b (down 12% from 1Q 2022). Net income: ₩1.49b (up 11% from 1Q 2022). Profit margin: 4.3% (up from 3.5% in 1Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 51% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₩5,380, the stock trades at a trailing P/E ratio of 67.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 350% over the past three years.Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩3,720, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 331% over the past three years.Valuation Update With 7 Day Price Move • Feb 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩3,120, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 179% over the past three years.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,415, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 122% over the past three years.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₩3,300, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 217% over the past three years.분석 기사 • Apr 03These 4 Measures Indicate That SamYoung ChemicalLtd (KRX:003720) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Mar 31Full year 2020 earnings released: EPS ₩6.00 (vs ₩59.00 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩117.7b (up 5.9% from FY 2019). Net income: ₩214.7m (up ₩2.23b from FY 2019). Profit margin: 0.2% (up from net loss in FY 2019). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.분석 기사 • Mar 08Investors Who Bought SamYoung ChemicalLtd (KRX:003720) Shares A Year Ago Are Now Up 160%When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...공시 • Mar 06SamYoung Chemical Co.,Ltd, Annual General Meeting, Mar 26, 2021SamYoung Chemical Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 10:00 Korea Standard Time.분석 기사 • Feb 10Is There More Growth In Store For SamYoung ChemicalLtd's (KRX:003720) Returns On Capital?There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...분석 기사 • Jan 14SamYoung Chemical Co.,Ltd's (KRX:003720) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?SamYoung ChemicalLtd's (KRX:003720) stock is up by a considerable 55% over the past three months. As most would know...Is New 90 Day High Low • Jan 07New 90-day high: ₩3,020The company is up 30% from its price of ₩2,325 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.분석 기사 • Dec 19These 4 Measures Indicate That SamYoung ChemicalLtd (KRX:003720) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is New 90 Day High Low • Dec 11New 90-day high: ₩2,560The company is up 31% from its price of ₩1,950 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.분석 기사 • Nov 23Investors Who Bought SamYoung ChemicalLtd (KRX:003720) Shares A Year Ago Are Now Up 100%It might be of some concern to shareholders to see the SamYoung Chemical Co.,Ltd (KRX:003720) share price down 12% in...Is New 90 Day High Low • Oct 12New 90-day high: ₩2,465The company is up 108% from its price of ₩1,185 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period.Is New 90 Day High Low • Sep 18New 90-day high: ₩2,330The company is up 88% from its price of ₩1,240 on 19 June 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period.매출 및 비용 세부 내역SamyoungLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSE:A003720 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 25153,20813,16910,9682,90430 Sep 25142,61910,06510,1423,12230 Jun 25127,9227,0579,2933,12231 Mar 25127,6268,9919,5782,91331 Dec 24126,0408,0629,5412,80630 Sep 24123,99514,3009,5432,50130 Jun 24122,38614,3739,6392,50131 Mar 24120,22312,8598,9702,70331 Dec 23122,58713,7298,8042,82730 Sep 23114,8487,0378,4433,41030 Jun 23123,4907,1929,6813,41031 Mar 23128,4535,54811,6133,54931 Dec 22135,2564,76411,5763,49230 Sep 22149,9194,85413,0673,39030 Jun 22142,9664,29612,5233,39031 Mar 22141,6074,40511,7353,52731 Dec 21133,2703,48111,3473,35930 Sep 21127,6631,48911,9102,92830 Jun 21122,88446111,2702,92831 Mar 21117,50552610,9932,84731 Dec 20117,65821510,7293,00130 Sep 20110,9802939,0473,12030 Jun 20111,990-2948,6363,12031 Mar 20114,673-1,0588,6322,60831 Dec 19111,144-2,0129,1122,34230 Sep 19111,296-3,4278,9842,96430 Jun 19109,271-4,3428,6272,96431 Mar 19103,959-5,7229,3592,65831 Dec 18102,948-6,8899,2382,72930 Sep 1897,922-18,6369,3773,34630 Jun 1897,741-19,7769,8233,34631 Mar 1898,680-21,1408,4793,77131 Dec 17100,355-21,4719,6692,65330 Sep 17105,663-11,14810,80364630 Jun 17102,673-9,4339,88164631 Mar 17110,835-8,07511,38510531 Dec 16113,636-7,00011,434030 Sep 16118,579-10,09111,744030 Jun 16125,404-11,87512,556031 Mar 16124,028-11,40611,951031 Dec 15126,121-11,55012,702030 Sep 15135,178-14,62213,204030 Jun 15144,090-14,68614,1450양질의 수익: A003720는 고품질 수익을 보유하고 있습니다.이익 마진 증가: A003720의 현재 순 이익률 (8.6%)은 지난해 (6.4%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A003720는 지난 5년 동안 흑자전환하며 연평균 35.8%의 수익 성장을 기록했습니다.성장 가속화: 지난 1년간 A003720 의 수익 증가율(63.3%)은 연간 평균(35.8%)을 초과합니다.수익 대 산업: A003720의 지난 1년 수익 증가율(63.3%)은 Chemicals 업계의 -3.4%를 상회했습니다.자기자본이익률높은 ROE: A003720의 자본 수익률(17%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 10:07종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Samyoung Co.,Ltd.는 3명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hyun Jung DohDaishin Securities Co. Ltd.Jun-Seo HeoEugene Investment & Securities Co Ltd.Joo-won AhnYuanta Securities Korea Co., Ltd.
Reported Earnings • Mar 21Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₩400 (up from ₩243 in FY 2024). Revenue: ₩153.2b (up 22% from FY 2024). Net income: ₩13.2b (up 63% from FY 2024). Profit margin: 8.6% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 19Second quarter 2025 earnings released: EPS: ₩43.00 (vs ₩101 in 2Q 2024)Second quarter 2025 results: EPS: ₩43.00 (down from ₩101 in 2Q 2024). Revenue: ₩33.4b (flat on 2Q 2024). Net income: ₩1.42b (down 58% from 2Q 2024). Profit margin: 4.3% (down from 10% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
분석 기사 • May 24Some Investors May Be Willing To Look Past SamyoungLtd's (KRX:003720) Soft EarningsThe most recent earnings report from Samyoung Co.,Ltd. ( KRX:003720 ) was disappointing for shareholders. However, our...
분석 기사 • Nov 22SamyoungLtd's (KRX:003720) Earnings Are Weaker Than They SeemDespite posting some strong earnings, the market for Samyoung Co.,Ltd.'s ( KRX:003720 ) stock hasn't moved much. We did...
Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩51.00 (vs ₩52.65 in 3Q 2023)Third quarter 2024 results: EPS: ₩51.00 (down from ₩52.65 in 3Q 2023). Revenue: ₩31.2b (up 5.4% from 3Q 2023). Net income: ₩1.69b (down 4.2% from 3Q 2023). Profit margin: 5.4% (down from 6.0% in 3Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
분석 기사 • Mar 31Why SamyoungLtd's (KRX:003720) Healthy Earnings Aren’t As Good As They SeemSolid profit numbers didn't seem to be enough to please Samyoung Co.,Ltd.'s ( KRX:003720 ) shareholders. Our analysis...
Valuation Update With 7 Day Price Move • May 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩13,180, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 201% over the past three years.
Buy Or Sell Opportunity • Apr 24Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 99% to ₩11,060. The fair value is estimated to be ₩9,119, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.
New Risk • Apr 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (74% net debt to equity). Share price has been volatile over the past 3 months (13% average weekly change).
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩8,130, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 124% over the past three years.
분석 기사 • Apr 13What Is Samyoung Co.,Ltd.'s (KRX:003720) Share Price Doing?While Samyoung Co.,Ltd. ( KRX:003720 ) might not have the largest market cap around , it received a lot of attention...
Buy Or Sell Opportunity • Apr 07Now 22% undervaluedOver the last 90 days, the stock has risen 16% to ₩6,800. The fair value is estimated to be ₩8,747, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.
Buy Or Sell Opportunity • Mar 23Now 21% undervaluedOver the last 90 days, the stock has risen 6.4% to ₩6,800. The fair value is estimated to be ₩8,605, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 22% in a year. Earnings are forecast to grow by 53% in the next year.
Reported Earnings • Mar 21Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: ₩400 (up from ₩243 in FY 2024). Revenue: ₩153.2b (up 22% from FY 2024). Net income: ₩13.2b (up 63% from FY 2024). Profit margin: 8.6% (up from 6.4% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 5.0%. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Mar 04Samyoung Co.,Ltd., Annual General Meeting, Mar 31, 2026Samyoung Co.,Ltd., Annual General Meeting, Mar 31, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 565, gyeongin-ro, guro-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩9,170, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 207% over the past three years.
분석 기사 • Feb 11Samyoung Co.,Ltd. (KRX:003720) Looks Just Right With A 46% Price JumpSamyoung Co.,Ltd. ( KRX:003720 ) shareholders have had their patience rewarded with a 46% share price jump in the last...
Valuation Update With 7 Day Price Move • Feb 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,530, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 133% over the past three years.
분석 기사 • Jan 12At ₩5,640, Is It Time To Put Samyoung Co.,Ltd. (KRX:003720) On Your Watch List?While Samyoung Co.,Ltd. ( KRX:003720 ) might not have the largest market cap around , it received a lot of attention...
Upcoming Dividend • Dec 22Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 6.5% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩7,460, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 186% over the past three years.
분석 기사 • Nov 27Subdued Growth No Barrier To Samyoung Co.,Ltd. (KRX:003720) With Shares Advancing 32%Samyoung Co.,Ltd. ( KRX:003720 ) shareholders have had their patience rewarded with a 32% share price jump in the last...
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment improves as stock rises 30%After last week's 30% share price gain to ₩6,000, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 125% over the past three years.
New Risk • Nov 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Profit margins are more than 30% lower than last year (5.5% net profit margin).
Declared Dividend • Nov 08Dividend of ₩20.00 announcedDividend of ₩20.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.4%, which is lower than the industry average of 1.7%.
공시 • Nov 07Samyoung Co.,Ltd. announces Annual dividend, payable on April 28, 2026Samyoung Co.,Ltd. announced Annual dividend of KRW 20.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩5,310, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 117% over the past three years.
New Risk • Aug 19New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risk Profit margins are more than 30% lower than last year (5.5% net profit margin).
Reported Earnings • Aug 19Second quarter 2025 earnings released: EPS: ₩43.00 (vs ₩101 in 2Q 2024)Second quarter 2025 results: EPS: ₩43.00 (down from ₩101 in 2Q 2024). Revenue: ₩33.4b (flat on 2Q 2024). Net income: ₩1.42b (down 58% from 2Q 2024). Profit margin: 4.3% (down from 10% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
분석 기사 • Aug 14Samyoung Co.,Ltd. (KRX:003720) Stocks Shoot Up 25% But Its P/E Still Looks ReasonableKOSE:A003720 1 Year Share Price vs Fair Value Explore SamyoungLtd's Fair Values from the Community and select yours...
공시 • Jun 19Samyoung Co.,Ltd. (KOSE:A003720) agreed to acquire 99.63% stake in CASCO Co., Ltd. from PTclover Co., Ltd. for KRW 35.5 billion.Samyoung Co.,Ltd. (KOSE:A003720) agreed to acquire 99.63% stake in CASCO Co., Ltd. from PTclover Co., Ltd. for KRW 35.5 billion on June 18, 2025. A cash consideration of KRW 35.5 billion will be paid by Samyoung Co.,Ltd. As part of consideration, KRW 35.5 billion is paid towards common equity of CASCO Co., Ltd. The expected completion of the transaction is July 1, 2025.
분석 기사 • May 24Some Investors May Be Willing To Look Past SamyoungLtd's (KRX:003720) Soft EarningsThe most recent earnings report from Samyoung Co.,Ltd. ( KRX:003720 ) was disappointing for shareholders. However, our...
분석 기사 • Apr 16Market Participants Recognise Samyoung Co.,Ltd.'s (KRX:003720) EarningsSamyoung Co.,Ltd.'s ( KRX:003720 ) price-to-earnings (or "P/E") ratio of 16.3x might make it look like a sell right now...
New Risk • Mar 27New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.4% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.4% net profit margin). Market cap is less than US$100m (₩131.9b market cap, or US$89.8m).
공시 • Mar 07Samyoung Co.,Ltd., Annual General Meeting, Mar 28, 2025Samyoung Co.,Ltd., Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 565, gyeongin-ro, guro-gu, seoul South Korea
분석 기사 • Feb 19Is SamyoungLtd (KRX:003720) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩4,835, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years.
분석 기사 • Jan 20We Ran A Stock Scan For Earnings Growth And SamyoungLtd (KRX:003720) Passed With EaseThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩4,325, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 33% over the past three years.
Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. Payout ratio is a comfortable 4.6% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₩3,750, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 31% over the past three years.
분석 기사 • Dec 09The Market Doesn't Like What It Sees From Samyoung Co.,Ltd.'s (KRX:003720) Earnings Yet As Shares Tumble 26%To the annoyance of some shareholders, Samyoung Co.,Ltd. ( KRX:003720 ) shares are down a considerable 26% in the last...
분석 기사 • Nov 22SamyoungLtd's (KRX:003720) Earnings Are Weaker Than They SeemDespite posting some strong earnings, the market for Samyoung Co.,Ltd.'s ( KRX:003720 ) stock hasn't moved much. We did...
Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩51.00 (vs ₩52.65 in 3Q 2023)Third quarter 2024 results: EPS: ₩51.00 (down from ₩52.65 in 3Q 2023). Revenue: ₩31.2b (up 5.4% from 3Q 2023). Net income: ₩1.69b (down 4.2% from 3Q 2023). Profit margin: 5.4% (down from 6.0% in 3Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
New Risk • Nov 05New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩137.8b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩137.8b market cap, or US$99.9m).
분석 기사 • Sep 26There's Been No Shortage Of Growth Recently For SamyoungLtd's (KRX:003720) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
분석 기사 • Sep 04Samyoung Co.,Ltd. (KRX:003720) Held Back By Insufficient Growth Even After Shares Climb 36%Samyoung Co.,Ltd. ( KRX:003720 ) shares have had a really impressive month, gaining 36% after a shaky period...
분석 기사 • Sep 03Do SamyoungLtd's (KRX:003720) Earnings Warrant Your Attention?The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₩3,080, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 8.6% over the past three years.
분석 기사 • Jun 18SamyoungLtd (KRX:003720) Is Looking To Continue Growing Its Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Mar 31Why SamyoungLtd's (KRX:003720) Healthy Earnings Aren’t As Good As They SeemSolid profit numbers didn't seem to be enough to please Samyoung Co.,Ltd.'s ( KRX:003720 ) shareholders. Our analysis...
New Risk • Mar 19New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.8b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₩132.8b market cap, or US$99.2m).
New Risk • Jan 25New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩132.7b (US$99.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (₩132.7b market cap, or US$99.4m).
New Risk • Nov 25New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 3.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks High level of debt (84% net debt to equity). Profit margins are more than 30% lower than last year (2.2% net profit margin).
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩4,930, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 172% over the past three years.
Reported Earnings • Aug 20Second quarter 2023 earnings released: EPS: ₩37.00 (vs ₩6.00 in 2Q 2022)Second quarter 2023 results: EPS: ₩37.00 (up from ₩6.00 in 2Q 2022). Revenue: ₩33.6b (down 6.4% from 2Q 2022). Net income: ₩1.25b (up ₩1.05b from 2Q 2022). Profit margin: 3.7% (up from 0.6% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.2b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks High level of debt (86% net debt to equity). Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (₩130.2b market cap, or US$99.5m).
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩4,840, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 240% over the past three years.
Reported Earnings • May 21First quarter 2023 earnings released: EPS: ₩44.00 (vs ₩40.00 in 1Q 2022)First quarter 2023 results: EPS: ₩44.00 (up from ₩40.00 in 1Q 2022). Revenue: ₩34.4b (down 12% from 1Q 2022). Net income: ₩1.49b (up 11% from 1Q 2022). Profit margin: 4.3% (up from 3.5% in 1Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 51% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improves as stock rises 33%After last week's 33% share price gain to ₩5,380, the stock trades at a trailing P/E ratio of 67.7x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 350% over the past three years.
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩3,720, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 331% over the past three years.
Valuation Update With 7 Day Price Move • Feb 22Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩3,120, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 179% over the past three years.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,415, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 122% over the past three years.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₩3,300, the stock trades at a trailing P/E ratio of 25x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 217% over the past three years.
분석 기사 • Apr 03These 4 Measures Indicate That SamYoung ChemicalLtd (KRX:003720) Is Using Debt Reasonably WellThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Mar 31Full year 2020 earnings released: EPS ₩6.00 (vs ₩59.00 loss in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: ₩117.7b (up 5.9% from FY 2019). Net income: ₩214.7m (up ₩2.23b from FY 2019). Profit margin: 0.2% (up from net loss in FY 2019). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
분석 기사 • Mar 08Investors Who Bought SamYoung ChemicalLtd (KRX:003720) Shares A Year Ago Are Now Up 160%When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...
공시 • Mar 06SamYoung Chemical Co.,Ltd, Annual General Meeting, Mar 26, 2021SamYoung Chemical Co.,Ltd, Annual General Meeting, Mar 26, 2021, at 10:00 Korea Standard Time.
분석 기사 • Feb 10Is There More Growth In Store For SamYoung ChemicalLtd's (KRX:003720) Returns On Capital?There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
분석 기사 • Jan 14SamYoung Chemical Co.,Ltd's (KRX:003720) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?SamYoung ChemicalLtd's (KRX:003720) stock is up by a considerable 55% over the past three months. As most would know...
Is New 90 Day High Low • Jan 07New 90-day high: ₩3,020The company is up 30% from its price of ₩2,325 on 08 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period.
분석 기사 • Dec 19These 4 Measures Indicate That SamYoung ChemicalLtd (KRX:003720) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Is New 90 Day High Low • Dec 11New 90-day high: ₩2,560The company is up 31% from its price of ₩1,950 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period.
분석 기사 • Nov 23Investors Who Bought SamYoung ChemicalLtd (KRX:003720) Shares A Year Ago Are Now Up 100%It might be of some concern to shareholders to see the SamYoung Chemical Co.,Ltd (KRX:003720) share price down 12% in...
Is New 90 Day High Low • Oct 12New 90-day high: ₩2,465The company is up 108% from its price of ₩1,185 on 14 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 30% over the same period.
Is New 90 Day High Low • Sep 18New 90-day high: ₩2,330The company is up 88% from its price of ₩1,240 on 19 June 2020. The South Korean market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period.